Neogen Chemicals Limited (NEOGEN) — deviation variation | 24 July 2026(2 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 deviation variation 🟡 Notable Neutral 📄 PDF
📢 Key Event
No deviation in fund utilization for preferential issue
💡 Investor Takeaway
Shareholders can be assured that the raised funds were used strictly as per the disclosed objectives with no variances.

Neogen Chemicals Limited disclosed that there was no deviation or variation in the utilization of funds raised through its April 18, 2026 preferential issue of equity shares for the quarter ended June 30, 2026. The company confirmed full utilization of the Rs. 161 crore proceeds across three stated objects: Rs. 100 crore for investment in Neogen Ionics Limited, Rs. 21 crore for working capital, and Rs. 40 crore for general corporate purposes, with no unexplained variances reported. The Audit Committee and CRISIL Monitoring Agency both validated compliance with the original fund allocation and shareholder approval requirements.

2 deviation variation 🟡 Notable Neutral 📄 PDF
📢 Key Event
No deviation in fund utilization for preferential issue
💡 Investor Takeaway
Shareholders can be assured that raised funds were used exactly as promised with no regulatory concerns.

Neogen Chemicals Limited confirmed no deviation in fund utilization for its June 30, 2026 quarter preferential issue, with all ₹161 crores deployed as originally disclosed across investment in Neogen Ionics Limited, working capital, and general corporate purposes. The company and CRISIL Ratings verified full compliance with SEBI regulations, uploading the monitoring report to its website and stock exchanges.

About Neogen Chemicals Limited (NEOGEN)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹4,392.02 Cr P/E: 88.9

View full NEOGEN stock details →

📡 Get AI alerts when NEOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEOGEN — Free

📊 More NEOGEN filings

See all NEOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEOGEN files new disclosures

Track NEOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NEOGEN — Free

Free account · 2 AI queries/day